Researchers from Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania have received a $5.3 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to conduct the Eliminating Monitor Overuse (EMO) clinical trial, seeking to discover how best to reduce the overuse of unnecessary monitoring strategies for infants who have a common lung infection called bronchiolitis. The goal is to reduce these commonplace practices that are currently unsupported by evidence, save patients and hospitals from the burden of unnecessary expenses, and focus on more effective methods of monitoring pediatric health.
Deimplementation studies seek to reduce practices that are overused by clinicians, especially those known to have little or no evidence of benefit.
“This will be one of the largest projects focused on deimplementation,” says Rinad Beidas, PhD, Director of the Penn Medicine Nudge Unit and the Penn Implementation Science Center at the Leonard Davis Institute (PISCE@LDI), Associate Professor of Psychiatry, Medical Ethics and Health Policy, and Medicine, and one of the principal investigators on this project. “Supporting people in not doing something is an area of research that has been less emphasized, and this project is specifically focused on sustainable change, which has been a challenge for the field.”